Jemal A, Bray F, Center MM, Ferlay J, Ward E et al (2011) Global cancer statistics. CA: Cancer J. Clin 61:69–90. https://doi.org/10.3322/caac.201072
Article
Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J. Clin 68(394):424–424. https://doi.org/10.3322/caac.21492
Article
Google Scholar
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750. https://doi.org/10.1002/hep.299132
Article
PubMed
Google Scholar
Bouter A, Carmeille R, Gounou C, Bouvet F, Degrelle S et al (2015) Annexin-A5 and cell membrane repair. Placenta 36:S43–SS9. https://doi.org/10.1016/j.placenta.2015.01.193
Article
CAS
PubMed
Google Scholar
Francesconi L, Ceresér K, Mascarenhas R, Stertz L, Gama C et al (2011) Increased annexin-V and decreased TNF-alpha serum levels in chronic-medicated patients with schizophrenia. Neurosci. Lett. 502:143–146. https://doi.org/10.1016/j.neulet.2011.06.0423
Article
CAS
PubMed
Google Scholar
Roldán V, Marn F, Pineda J, Marco P, Corral J, Climent V, García A, Martínez JG, Sogorb F (2002) nexina V en pacientes supervivientes de un infarto de miocardio prematuro. Rev Esp Cardiol. 55:1230–1234. https://doi.org/10.1016/S0300-8932(02)76794-812
Article
PubMed
Google Scholar
Lai C, Pc C, Wong S, Kw C, Yf C. (2012). Circulating Annexin A5 levels after atrial switch for transposition of the great arteries.
Mirsaeidi M, Gidfar S, Vu A, Schraufnagel D (2016) Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis. J Transl Med 14:1–9. https://doi.org/10.1186/s12967-016-0843-71
Kaneko N, Matsuda R, Hosoda S, Kajita T, Ohta Y (1996) Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin. Chim. Acta 251:65–80. https://doi.org/10.1016/0009-8981(96)06294-81
Article
CAS
PubMed
Google Scholar
Velázquez RF, Rodríguez M, Navascués CA, Linares A, Pérez R et al (2003) Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 37:520–527. https://doi.org/10.1053/jhep.2003.500933
Article
PubMed
Google Scholar
Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA (2018) (2018). AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380. https://doi.org/10.1002/hep.290861
Article
PubMed
Google Scholar
Kulik L, El-Serag HB (2019) Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156:477-91. e1.https://doi.org/10.1053/j.gastro.2018.08.065. 156(2):477–491.e1
Wang J, Zhang Y, Liu X, Ma J, Liu P et al (2014) Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signaling. Oncol. Rep. 32:2557–2563. https://doi.org/10.3892/or.2014.35476
Article
CAS
PubMed
Google Scholar
Peng B, Guo C, Guan H, Liu S, Sun M-Z (2014) Annexin A5 as a potential marker in tumors. Clin. Chim. Acta 427:42–48 https://doi.org/10.1016/j.cca.2013.09.048
Article
CAS
Google Scholar
Guo W-X, Man X-B, Yuan H-X, Shi J, Xue J, Wu MC, Cheng SQ (2007). Proteomic analysis on portal vein tumor thrombus-associated proteins for hepatocellular carcinoma. Zhonghua yi xue za zhi 87:2094-2097. PMID: 17988525, 30
Sun X, Liu S, Wang J, Wei B, Guo C, Chen C, Sun MZ et al (2018) Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways. Cell Death Dis. 9:1–16. https://doi.org/10.1038/s41419-018-0685-86
Zhuang C, Wang P, Sun T, Zheng L, Ming L (2019) Expression levels and prognostic values of annexins in liver cancer. Oncol. Lett. 18:6657–6669 https://doi.org/10.3892/ol.2019.11025
CAS
PubMed
PubMed Central
Google Scholar
Ravassa S, Bennaghmouch A, Kenis H, Lindhout T, Hackeng T, Narula J, Hofstra L, Reutelingsperger C (2005) Annexin A5 down-regulates surface expression of tissue factor a novel mechanism of regulating the membrane receptor repertoir. J. Biol. Chem. 280:6028–6035. https://doi.org/10.1074/jbc.M4117102007
Baleva M, Hristova M, Nikolov K (2010) Diagnostic significance of anti-annexin-A5 antibody determination. Open Med. 5:6–11. https://doi.org/10.2478/s11536-009-0132-41
Article
CAS
Google Scholar
Corsten MF, Hofstra L, Narula J, Reutelingsperger CP (2006) Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance. Cancer Res 66(3):1255–1260. https://doi.org/10.1158/0008-5472.CAN-05-3000
Article
CAS
PubMed
Google Scholar
Brodsky SV, Facciuto ME, Heydt D, Chen J, Islam HK, et al.(2008). Dynamics of circulating microparticles in liver transplant patients. J Gastrointestin Liver Dis 17:261-268. PMID: 18836617
Rautou PE, Bresson J, Sainte-Marie Y, Vion AC, Paradis V et al (2012) Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology 143:166–76.e6. https://doi.org/10.1053/j.gastro.2012.03.040
Article
CAS
PubMed
Google Scholar